In regard to their potential to identify disease and its progression, patients with kidney diseases have higher levels of urinary adiponectin, lipocalin-2, leptin, galectin-3 and IL-6 (Table 1) [67,130,156,174,212]. This evidence concerns the gene IL6 and kidney disorder.